Enter your email address:

Delivered by FeedBurner

Zydus Cadila to commence phase II clinical trials of COVID-19 vaccine ZyCoV-D from Aug 6

"The company reports that the doses of the vaccine administered to
healthy volunteers in the phase I clinical trial, which began on July
15, 2020, has been well tolerated," Cadila Healthcare, the listed
entity of the group, said in a regulatory filing. Zydus Cadila
Chairman Pankaj R Patel said the phase I dosing to establish the
safety of ZyCoV-D is an important milestone.



Post a Comment